Nakayama Hisashi, Takayama Tadatoshi
Hisashi Nakayama, Tadatoshi Takayama, Department of Digestive Surgery, Nihon University School of Medicine, Itabashi-ku, Tokyo 173-8610, Japan.
World J Hepatol. 2015 Feb 27;7(2):261-9. doi: 10.4254/wjh.v7.i2.261.
In the Algorithm for Diagnosis and Treatment in the Japanese Evidence-Based Clinical Practice Guidelines for Hepatocellular Carcinoma, the treatment strategy is determined by three major factors: liver function and the number and size of tumors. The algorithm is quite simple, consisting of fewer components than the Barcelona-Clinic Liver Cancer staging system. In this article, we describe the roles of the treatment algorithm in hepatectomy and perioperative management of hepatocellular carcinoma.
在日本肝细胞癌循证临床实践指南的诊断与治疗算法中，治疗策略由三个主要因素决定：肝功能、肿瘤数量及大小。该算法相当简单，组成部分比巴塞罗那临床肝癌分期系统更少。在本文中，我们描述了该治疗算法在肝细胞癌肝切除术及围手术期管理中的作用。
